Bollard Group’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.92M Sell
1,352,276
-71,900
-5% -$102K 0.04% 88
2025
Q1
$2.18M Buy
+1,424,176
New +$2.18M 0.06% 82